11.05.2022 12:53:04
|
Johnson & Johnson Names CEO, CFO Designates Of New Consumer Health Company
(RTTNews) - Johnson & Johnson (JNJ) announced Wednesday the appointment of Thibaut Mongon as Chief Executive Officer Designate and Paul Ruh as Chief Financial Officer Designate of New Consumer Health Company that will be created following the planned separation.
The appointments will occur upon completion of the planned separation of the Consumer Health business, expected within 2023, subject to legal requirements.
Directors and additional executive leadership appointments will be decided in the coming months as the planned separation process progresses.
Mongon has served as Executive Vice President and Worldwide Chairman of Consumer Health at Johnson & Johnson since 2019. He has more than 20 years of global experience at Johnson & Johnson.
Ruh joined Johnson & Johnson five years ago to become the CFO of the Consumer Health business. Prior to that, he was with PepsiCo in the position of CFO of Latin America from 2015 until January 2017.
It was in November 2021 that Johnson & Johnson announced the planned separation to create two global leaders, such as the new Johnson & Johnson and the New Consumer Health Company.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Johnson & Johnsonmehr Nachrichten
18.12.24 |
Dow Jones-Handel aktuell: Dow Jones letztendlich mit Abgaben (finanzen.at) | |
18.12.24 |
Dow Jones 30 Industrial-Papier Johnson Johnson-Aktie: So viel Verlust hätte ein Investment in Johnson Johnson von vor einem Jahr eingebracht (finanzen.at) | |
17.12.24 |
Dow Jones-Handel aktuell: Dow Jones legt zum Handelsende den Rückwärtsgang ein (finanzen.at) | |
17.12.24 |
NYSE-Handel Dow Jones am Dienstagnachmittag mit Abgaben (finanzen.at) | |
17.12.24 |
Dow Jones-Handel aktuell: Dow Jones fällt (finanzen.at) | |
16.12.24 |
Schwacher Handel in New York: Dow Jones schlussendlich in Rot (finanzen.at) | |
11.12.24 |
Angespannte Stimmung in New York: Dow Jones beendet die Mittwochssitzung im Minus (finanzen.at) | |
11.12.24 |
Schwache Performance in New York: Dow Jones notiert nachmittags im Minus (finanzen.at) |
Analysen zu Johnson & Johnsonmehr Analysen
Aktien in diesem Artikel
Johnson & Johnson | 139,42 | 0,11% |